Literature DB >> 22324996

Cerebral malaria pathogenesis: revisiting parasite and host contributions.

Georges Emile Raymond Grau1, Alister Gordon Craig.   

Abstract

Cerebral malaria is one of a number of clinical syndromes associated with infection by human malaria parasites of the genus Plasmodium. The etiology of cerebral malaria derives from sequestration of parasitized red cells in brain microvasculature and is thought to be enhanced by the proinflammatory status of the host and virulence characteristics of the infecting parasite variant. In this article we examine the range of factors thought to influence the development of Plasmodium falciparum cerebral malaria in humans and review the evidence to support their role.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22324996     DOI: 10.2217/fmb.11.155

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  40 in total

Review 1.  Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease.

Authors:  Peter D Crompton; Jacqueline Moebius; Silvia Portugal; Michael Waisberg; Geoffrey Hart; Lindsey S Garver; Louis H Miller; Carolina Barillas-Mury; Susan K Pierce
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

2.  Targeting glutamine metabolism rescues mice from late-stage cerebral malaria.

Authors:  Emile B Gordon; Geoffrey T Hart; Tuan M Tran; Michael Waisberg; Munir Akkaya; Ann S Kim; Sara E Hamilton; Mirna Pena; Takele Yazew; Chen-Feng Qi; Chen-Fang Lee; Ying-Chun Lo; Louis H Miller; Jonathan D Powell; Susan K Pierce
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-05       Impact factor: 11.205

Review 3.  Malaria Pathogenesis.

Authors:  Danny A Milner
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

4.  Neurocognitive sequelae of cerebral malaria in adults: a pilot study in Benguela Central Hospital, Angola.

Authors:  Bruno Peixoto; Isabel Kalei
Journal:  Asian Pac J Trop Biomed       Date:  2013-07

5.  The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria.

Authors:  Theresa N Ramos; Meghan M Darley; Sebastian Weckbach; Philip F Stahel; Stephen Tomlinson; Scott R Barnum
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

6.  Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African children.

Authors:  Christopher A Moxon; Samuel C Wassmer; Danny A Milner; Ngawina V Chisala; Terrie E Taylor; Karl B Seydel; Malcolm E Molyneux; Brian Faragher; Charles T Esmon; Colin Downey; Cheng-Hock Toh; Alister G Craig; Robert S Heyderman
Journal:  Blood       Date:  2013-06-05       Impact factor: 22.113

7.  Spatial and temporal mapping of the PfEMP1 export pathway in Plasmodium falciparum.

Authors:  Paul J McMillan; Coralie Millet; Steven Batinovic; Mauro Maiorca; Eric Hanssen; Shannon Kenny; Rebecca A Muhle; Martin Melcher; David A Fidock; Joseph D Smith; Matthew W A Dixon; Leann Tilley
Journal:  Cell Microbiol       Date:  2013-03-14       Impact factor: 3.715

8.  Genetic variability in platelet integrin α2β1 density: possible contributor to Plasmodium vivax-induced severe thrombocytopenia.

Authors:  Fernanda M F Campos; Marina L S Santos; Flora S Kano; Cor J F Fontes; Marcus V G Lacerda; Cristiana F A Brito; Luzia H Carvalho
Journal:  Am J Trop Med Hyg       Date:  2012-12-18       Impact factor: 2.345

9.  Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.

Authors:  W Armand Guiguemde; Nicholas H Hunt; Jintao Guo; Annael Marciano; Richard K Haynes; Julie Clark; R Kiplin Guy; Jacob Golenser
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

Review 10.  Desperately Seeking Therapies for Cerebral Malaria.

Authors:  Brittany A Riggle; Louis H Miller; Susan K Pierce
Journal:  J Immunol       Date:  2020-01-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.